Delivery Order SPE2DB20D1109-SPE2DB24FP84V

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $93K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $8,003.82 firm-fixed-price delivery order is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of June 9, 2025 and is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, valued at $2,159.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $8,212.23 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DB22D3009) from the Defense Logistics Agency (DLA) Troop Support Medical. The $9,471.49 firm fixed-price contract is for the supply of the medication Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, with a Firm Fixed Price of $7,200.73 and a completion date of January 15, 2025. The IDC, valued at $999,999,999, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This contract award to AmerisourceBergen Drug Corp's Corporate Office division is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999 through December 2025, provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order is for the drug Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, with a...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a Delivery Order valued at $1,161.08 for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, placed by the Defense Logistics Agency (DLA). The contract has a period of performance through November 7, 2024 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,669.53 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of the diabetes medication Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, with an ultimate completion date of October 29, 2024. The contract is a firm-fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,161.08 firm fixed-price delivery order is for the supply of the medication Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November...
This federal contract award to AmerisourceBergen Drug Corp, valued at $12,989.65, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP84V
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, valued at $92,883.20, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is a $999,999,999 vehicle that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The specific contract award is for the drug Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This is a firm fixed-price contract with a completion date of September 6, 2024. The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, including the DLA, which manages the procurement and distribution of pharmaceuticals and medical supplies for the U.S. military and other federal healthcare programs.

Generated 2/27/25, 12:23 PM